Dr. Kurian’s research focuses on cancer genetics, precision oncology and the quality of cancer care at the population level. One current area of investigation is the utility of next-generation sequencing technology for clinical decision-making. Dr. Kurian's research has been supported by the National Cancer Institute, Susan G. Komen for the Cure, the American Society of Clinical Oncology, the California Breast Cancer Research Program, the Cancer Research and Prevention Foundation, the Robert Wood Johnson Foundation, the Breast Cancer Research Foundation and the BRCA Foundation.